Atlas Trials

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk

Clinical trial NCT03417336 · RECRUITING

Trial details

NCT number
NCT03417336
Sponsor
Centre Georges Francois Leclerc
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
To Evaluate the Rate of Digestive and Urinary Toxicity
Start date
2018-01-24
Primary completion
2029-04-24
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.